AHA Coding Clinic® for HCPCS - 2006 Quarter 1; FOR your INFORMATION
Coding clarification for sodium hyaluronan products
In the following table are HCPCS codes for sodium hyaluronan products that will continue to be recognized under the OPPS effective January 1, 2006: Code - Code descriptor C9220 Sodium Hyaluronan per 30 mg dose, for intra-articular injection J7317 Sodium Hyaluronan per 20 to 25 dose, for intra-articular injection J7320 Hylan G-F 20, 16 mg, for intra-articular injection ...
Subscribe or sign in to view the full article.
Article Overview
This short coding clarification is aimed at medical coders and revenue cycle staff who work with HCPCS reporting under the OPPS. It identifies the product-focused guidance discussed in the article and points readers to the specific HCPCS identifiers included in the source.
Why This Topic Matters
Facilities and coding teams need to know which HCPCS product codes are discussed so they can locate the relevant reimbursement and reporting guidance for sodium hyaluronan products under the OPPS.
What You Will Learn
- Which coding topic the article addresses
- Which HCPCS product identifiers are referenced
- What general coverage area the clarification relates to under OPPS
- Which timeframe is mentioned in the source
Who Should Read This
- Hospital outpatient coders
- Revenue integrity staff
- Billing specialists
- Charge description master teams
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com